|
BIO / BIOTECH / European Union / Monday, 06 February 2012 23:14
|
A European team of scientists has discovered how cells accurately inherit information that is not contained in their genes. The research, presented in the journal Developmental Cell, was funded in part by the EPICENTROMERE ('Determining the epigenetic mechanism of centromere propagation') project, which has clinched a Marie Curie Action 'International Reintegration Grant' worth EUR 100 000 under the EU's Seventh Framework Programme (FP7). The results help piece together a puzzle on...
|
|
Last Updated on Monday, 06 February 2012 23:20
|
|
BIO / BIOTECH / Exelixis Inc. / Friday, 03 February 2012 19:14
|
14.7 months median progression free survival
28% confirmed partial response rate & 72% disease control rate at week 16
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Feb. 3, 2012-- Exelixis, Inc. (NASDAQ:EXEL) today reported preliminary data from a cohort of heavily pretreated patients with metastatic refractory renal cell carcinoma (RCC) participating in an ongoing phase 1b trial of cabozantinib. Toni K. Choueiri, M.D., Director of the Kidney Cancer...
|
|
Last Updated on Friday, 03 February 2012 19:15
|
|
BIO / BIOTECH / European Union / Tuesday, 31 January 2012 16:50
|
A team of EU-funded researchers has successfully identified a gene that triggers a skin disorder in dogs - and the findings could have implications for humans who also suffer from the condition. Whether it manifests in golden retrievers or in humans, the disease ichthyosis has the same common genetic basis; therefore, any new bounds made in understanding the condition in dogs are applicable to humans too. No molecular cause for ichthyosis has previously been identified.
Humans...
|
|
Last Updated on Tuesday, 31 January 2012 16:51
|
|
BIO / BIOTECH / European Union / Thursday, 26 January 2012 10:43
|
Scientists in Finland have discovered how a biochemical signature can potentially predict progression to Alzheimer's disease. The study is funded in part by the PREDICTAD ('From patient data to personalised healthcare in Alzheimer's disease') project, which received almost EUR 2.9 million under the 'Information and communication technologies' (ICT) Theme of the Seventh Framework Programme (FP7). Results suggest that this neurological disorder is preceded by a molecular signature...
|
|
Last Updated on Thursday, 26 January 2012 10:44
|
|
BIO / BIOTECH / Exelixis Inc. / Wednesday, 25 January 2012 09:21
|
Data Highlight Progression Free Survival of 4.2 months in both sorafenib-pretreated and -naïve patients
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Jan. 20, 2012-- Exelixis, Inc. (NASDAQ:EXEL) today reported positive preliminary data from the cohort of hepatocellular carcinoma (HCC) patients participating in the ongoing phase 2 randomized discontinuation trial (RDT) of cabozantinib. Allan Lee Cohn, M.D., Medical Director of Research at the Rocky Mountain Cancer Centers, will present the...
|
|
Last Updated on Wednesday, 25 January 2012 09:24
|
|
BIO / BIOTECH / Delpor / Wednesday, 18 January 2012 22:21
|
Delpor continues to strengthen its expertise in drug delivery with the addition of the former CEO of Glaxo and Alza to its Board of Directors.
SAN FRANCISCO, CA, January 19, 2011 – Delpor, Inc. (Delpor), a biotechnology company focused on drug delivery of antipsychotics and biologics, today announced that Dr. Ernest Mario has joined the company’s Board of Directors.
“It is a big honor and a privilege that Ernie has joined our Board,” said Tassos Nicolaou, President and CEO...
|
|
Last Updated on Wednesday, 18 January 2012 22:25
|
|
BIO / BIOTECH / EKT / National Documentation Center / Wednesday, 18 January 2012 22:08
|
Έναν νέο μη αναμενόμενο μηχανισμό εκφυλισμού των νευρικών κυττάρων ανακάλυψαν οι ερευνητές του Ινστιτούτου Μοριακής Βιολογίας και Βιοτεχνολογίας (ΙΜΒΒ) του Ιδρύματος Τεχνολογίας και Έρευνας (ΙΤΕ) Κωστούλα Τρουλλινάκη και Νεκτάριος Ταβερναράκης. Τα...
|
|
Last Updated on Wednesday, 18 January 2012 22:10
|
|
|
| Page 1 of 23 |
|
